Enterobacteriaceae
Jump to navigation
Jump to search
Epidemiology
- emergence of carbapenem-resistant Enterobacteriaceae
- emergence of multidrug-resistant enterobacteriaceae
Laboratory
- Enterobacteriaceae carbapenemase-resistant identified by culture
- antibiotic susceptibility testing
- carbapenemase-producing Klebsiella spp. & E coli represent the major carbapenem-resistant Enterobacteriaceae in the USA[2]
- glucose fermenter; cytochrome-oxidase -; catalase +
- Enterobacteriaceae DNA
Management
- 3rd generation cephalosporin
- carbapenem (resistance has emerged)
- alternative: beta-lactam/beta-lactamase inhibitor
- discharge home to complete therapy with oral agents in complicated cases[2]
More general terms
More specific terms
- carbapenem-resistant Enterobacteriaceae (CRE)
- Citrobacter
- Cronobacter
- Edwardsiella
- Enterobacter
- Erwinia
- Escherichia
- Hafnia
- Klebsiella
- Morganella
- Proteus
- Providencia
- Salmonella
- Serratia
- Shigella
- Yersinia
Additional terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 15, 18 American College of Physicians, Philadelphia 2009, 2018
- ↑ 2.0 2.1 2.2 Tamma PD, Conley AT, Cosgrove SE et al. Association of 30-day mortality with oral step-down vs continued intravenous therapy in patients hospitalized with Enterobacteriaceae bacteremia. JAMA Intern Med 2019 Mar; 179:316-323 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30667477 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2720756